Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedram Razavi

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2019
Cyclin E mRNA: Assessing Cyclin-Dependent Kinase (CDK) Activation State to Elucidate Breast Cancer Resistance to CDK4/6 InhibitorsSarat Chandarlapaty, Pedram Razavi
Therapeutic Advances in Medical Oncology|August 4, 2022
Next-generation selective estrogen receptor degraders and other novel endocrine therapies for management of metastatic hormone receptor-positive breast cancer: current and emerging roleMaxwell R Lloyd, Seth A Wander, Erika Hamilton, et al.
JCO Clinical Cancer Informatics|May 14, 2021
Automated NLP Extraction of Clinical Rationale for Treatment Discontinuation in Breast CancerMatthew S Alkaitis, Monica N Agrawal, Gregory J Riely, et al.
Journal of the National Cancer Institute|February 22, 2011
Rotating night shifts and risk of skin cancer in the nurses' health studyEva S Schernhammer, Pedram Razavi, Tricia Y Li, et al.
Breast Cancer Research : BCR|November 29, 2012
Alcohol and breast cancer risk among Asian-American women in Los Angeles CountyAnna H Wu, Cheryl Vigen, Pedram Razavi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 21, 2010
Long-term postmenopausal hormone therapy and endometrial cancerPedram Razavi, Malcolm C Pike, Pamela L Horn-Ross, et al.
International Journal of Cancer|May 6, 2011
Variations in sex hormone metabolism genes, postmenopausal hormone therapy and risk of endometrial cancerPedram Razavi, Eunjung Lee, Leslie Bernstein, et al.
Breast Cancer Research and Treatment|March 24, 2026
Rb expression in metastatic ER-positive breast cancer: implications for precision oncologyDoaa Morrar, Dara Ross, Pedram Razavi, et al.
Breast Cancer Research : BCR|January 31, 2026
Sequential use of PI3K/AKT/mTOR pathway inhibitors alpelisib and everolimus in patients with hormone receptor-positive metastatic breast cancerSherry Shen, Jimmitti Teysir, Anton Safonov, et al.
British Journal of Haematology|April 27, 2012
Outcome disparities in multiple myeloma: a SEER-based comparative analysis of ethnic subgroupsSikander Ailawadhi, Ibrahim T Aldoss, Dongyun Yang, et al.
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2019
Cyclin E mRNA: Assessing Cyclin-Dependent Kinase (CDK) Activation State to Elucidate Breast Cancer Resistance to CDK4/6 InhibitorsSarat Chandarlapaty, Pedram Razavi
Therapeutic Advances in Medical Oncology|August 4, 2022
Next-generation selective estrogen receptor degraders and other novel endocrine therapies for management of metastatic hormone receptor-positive breast cancer: current and emerging roleMaxwell R Lloyd, Seth A Wander, Erika Hamilton, et al.
JCO Clinical Cancer Informatics|May 14, 2021
Automated NLP Extraction of Clinical Rationale for Treatment Discontinuation in Breast CancerMatthew S Alkaitis, Monica N Agrawal, Gregory J Riely, et al.
Journal of the National Cancer Institute|February 22, 2011
Rotating night shifts and risk of skin cancer in the nurses' health studyEva S Schernhammer, Pedram Razavi, Tricia Y Li, et al.
Breast Cancer Research : BCR|November 29, 2012
Alcohol and breast cancer risk among Asian-American women in Los Angeles CountyAnna H Wu, Cheryl Vigen, Pedram Razavi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 21, 2010
Long-term postmenopausal hormone therapy and endometrial cancerPedram Razavi, Malcolm C Pike, Pamela L Horn-Ross, et al.
International Journal of Cancer|May 6, 2011
Variations in sex hormone metabolism genes, postmenopausal hormone therapy and risk of endometrial cancerPedram Razavi, Eunjung Lee, Leslie Bernstein, et al.
Breast Cancer Research and Treatment|March 24, 2026
Rb expression in metastatic ER-positive breast cancer: implications for precision oncologyDoaa Morrar, Dara Ross, Pedram Razavi, et al.
Breast Cancer Research : BCR|January 31, 2026
Sequential use of PI3K/AKT/mTOR pathway inhibitors alpelisib and everolimus in patients with hormone receptor-positive metastatic breast cancerSherry Shen, Jimmitti Teysir, Anton Safonov, et al.
British Journal of Haematology|April 27, 2012
Outcome disparities in multiple myeloma: a SEER-based comparative analysis of ethnic subgroupsSikander Ailawadhi, Ibrahim T Aldoss, Dongyun Yang, et al.
Pageof 13